197 related articles for article (PubMed ID: 32436117)
1. Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
Wang F; Gao Y; Lv Y; Wu Y; Guo Y; Du F; Wang S; Yu J; Cao X; Li PA
J Neurooncol; 2020 Jun; 148(2):259-271. PubMed ID: 32436117
[TBL] [Abstract][Full Text] [Related]
2. Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes.
Li X; Isono K; Yamada D; Endo TA; Endoh M; Shinga J; Mizutani-Koseki Y; Otte AP; Casanova M; Kitamura H; Kamijo T; Sharif J; Ohara O; Toyada T; Bernstein BE; Brockdorff N; Koseki H
Mol Cell Biol; 2011 Jan; 31(2):351-64. PubMed ID: 21059868
[TBL] [Abstract][Full Text] [Related]
3. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
J Virol; 2019 May; 93(9):. PubMed ID: 30814291
[TBL] [Abstract][Full Text] [Related]
4. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
[TBL] [Abstract][Full Text] [Related]
5. Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.
Lee CH; Yu JR; Granat J; Saldaña-Meyer R; Andrade J; LeRoy G; Jin Y; Lund P; Stafford JM; Garcia BA; Ueberheide B; Reinberg D
Genes Dev; 2019 Oct; 33(19-20):1428-1440. PubMed ID: 31488577
[TBL] [Abstract][Full Text] [Related]
6. Polycomblike 2 facilitates the recruitment of PRC2 Polycomb group complexes to the inactive X chromosome and to target loci in embryonic stem cells.
Casanova M; Preissner T; Cerase A; Poot R; Yamada D; Li X; Appanah R; Bezstarosti K; Demmers J; Koseki H; Brockdorff N
Development; 2011 Apr; 138(8):1471-82. PubMed ID: 21367819
[TBL] [Abstract][Full Text] [Related]
7. PICOT binding to the polycomb group protein, EED, alters H3K27 methylation at the MYT1 PRC2 target gene.
Pandya P; Pasvolsky R; Babichev Y; Braiman A; Witte S; Altman A; Isakov N
Biochem Biophys Res Commun; 2019 Feb; 509(2):469-475. PubMed ID: 30595380
[TBL] [Abstract][Full Text] [Related]
8. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.
Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP
Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505
[TBL] [Abstract][Full Text] [Related]
9. Polycomb-like 3 promotes polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal.
Hunkapiller J; Shen Y; Diaz A; Cagney G; McCleary D; Ramalho-Santos M; Krogan N; Ren B; Song JS; Reiter JF
PLoS Genet; 2012; 8(3):e1002576. PubMed ID: 22438827
[TBL] [Abstract][Full Text] [Related]
10. miR‑767‑5p inhibits glioma proliferation and metastasis by targeting SUZ12.
Zhang J; Xu S; Xu J; Li Y; Zhang J; Zhang J; Lu X
Oncol Rep; 2019 Jul; 42(1):55-66. PubMed ID: 31115583
[TBL] [Abstract][Full Text] [Related]
11. An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.
Qi W; Zhao K; Gu J; Huang Y; Wang Y; Zhang H; Zhang M; Zhang J; Yu Z; Li L; Teng L; Chuai S; Zhang C; Zhao M; Chan H; Chen Z; Fang D; Fei Q; Feng L; Feng L; Gao Y; Ge H; Ge X; Li G; Lingel A; Lin Y; Liu Y; Luo F; Shi M; Wang L; Wang Z; Yu Y; Zeng J; Zeng C; Zhang L; Zhang Q; Zhou S; Oyang C; Atadja P; Li E
Nat Chem Biol; 2017 Apr; 13(4):381-388. PubMed ID: 28135235
[TBL] [Abstract][Full Text] [Related]
12. Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation.
Walker E; Chang WY; Hunkapiller J; Cagney G; Garcha K; Torchia J; Krogan NJ; Reiter JF; Stanford WL
Cell Stem Cell; 2010 Feb; 6(2):153-66. PubMed ID: 20144788
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.
Peruzzi P; Bronisz A; Nowicki MO; Wang Y; Ogawa D; Price R; Nakano I; Kwon CH; Hayes J; Lawler SE; Ostrowski MC; Chiocca EA; Godlewski J
Neuro Oncol; 2013 Sep; 15(9):1212-24. PubMed ID: 23733246
[TBL] [Abstract][Full Text] [Related]
14. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
[TBL] [Abstract][Full Text] [Related]
15. PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencing.
Fong KW; Zhao JC; Lu X; Kim J; Piunti A; Shilatifard A; Yu J
Mol Cell; 2022 Dec; 82(24):4611-4626.e7. PubMed ID: 36476474
[TBL] [Abstract][Full Text] [Related]
16. Embryonic Ectoderm Development (EED) as a Novel Target for Cancer Treatment.
Cook N; Chen J; Zhou J; Wu D
Curr Top Med Chem; 2021; 21(31):2771-2777. PubMed ID: 34544341
[TBL] [Abstract][Full Text] [Related]
17. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
18. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.
Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W
Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.
Piunti A; Hashizume R; Morgan MA; Bartom ET; Horbinski CM; Marshall SA; Rendleman EJ; Ma Q; Takahashi YH; Woodfin AR; Misharin AV; Abshiru NA; Lulla RR; Saratsis AM; Kelleher NL; James CD; Shilatifard A
Nat Med; 2017 Apr; 23(4):493-500. PubMed ID: 28263307
[TBL] [Abstract][Full Text] [Related]
20. The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.
Streubel G; Watson A; Jammula SG; Scelfo A; Fitzpatrick DJ; Oliviero G; McCole R; Conway E; Glancy E; Negri GL; Dillon E; Wynne K; Pasini D; Krogan NJ; Bracken AP; Cagney G
Mol Cell; 2018 Apr; 70(2):371-379.e5. PubMed ID: 29606589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
